Electrode patch for health monitoring

ABSTRACT

A method of measuring bioelectric signals of a patient having an axis extending from the patient&#39;s head to the patient&#39;s feet includes attaching a patch to the patient&#39;s skin. The patch may include a first electrode and a second electrode spaced apart along a longitudinal axis of the patch. The patch may be attached such that the longitudinal axis of the patch is generally aligned with the axis of the patient. The method may also include attaching a third electrode to the patient&#39;s skin, and measuring bioelectric signals of the patient using the first electrode, the second electrode, and the third electrode.

CROSS-REFERENCE TO RELATED APPLICATIONS

This application claims the benefits of priority from U.S. ProvisionalApplication No. 62/237,118, filed on Oct. 5, 2015, the disclosure ofwhich is incorporated by reference herein in its entirety.

TECHNICAL FIELD

Various embodiments of the present disclosure relate to an electrodepatch and systems and methods of using an electrode patch for healthmonitoring, and more particularly, to an electrode patch and systems andmethods of using an electrode patch for physiologic data monitoring.

BACKGROUND

Physiologic data may be used to monitor the health of a patient. Forexample, bioelectric signals (e.g., electrocardiogram or ECG signals)from the patient's heart may be used to monitor cardiac health. ECG is arecording of the electrical activity of the heart. During ECGmonitoring, electrodes attached to a patient's skin are used to detectelectrical activity of the heart over a period of time. During ECGmonitoring, electrical impulses generated by the heart during eachheartbeat are detected and recorded and/or displayed on a device.Analysis of the data reveals the cardiac health (e.g., rate andregularity of heartbeats, size and position of the chambers, thepresence of any damage to the heart, effects of drugs or devices used toregulate the heart, etc.) of the patient.

Multiple electrodes (e.g., left arm (LA), right arm (RA), and left leg(LL) electrodes) may be attached to the patient's skin for ECGmeasurement. These electrodes may be combined into a number of pairs(e.g., three pairs LA-RA, LA-LL, and RA-LL), and voltage signals may berecorded across each pair. Each pair is known as a lead. Each lead looksat the heart from a different angle. Different types of ECG measurementscan be referred to by the number of leads that are recorded (e.g.,3-lead, 5-lead, 12-lead ECG, etc.).

Many cardiac problems become noticeable only during physical activity(walking, exercise, etc.). An ambulatory electrocardiogram (ECG)continuously monitors the electrical activity of the heart while apatient does normal activities. Typically, a 12-lead or a 5-lead ECG isused for periodic ECG monitoring (e.g., at a doctor's office, etc.) anda 3-lead ECG is used for continuous ambulatory monitoring. In 3-leadmonitoring, ECG data is collected using three electrodes attached to thepatient. The collected data is recorded in a monitor operatively coupledto the electrodes. The stored data is analyzed by a health careprovider. In some cases, the monitor may transmit ECG data to a healthcare provider for analysis. Several types of monitors (e.g., Holtermonitor, event monitors, mobile cardiovascular telemetry monitors, etc.)are known in the art. Some of these monitors store the data forsubsequent analysis by a health care provider, while others transmit(real-time, periodically, or on demand) the collected ECG data to aremote site where it is analyzed.

Regardless of the type of ECG measurement, the quality of themeasurement depends on the attachment quality and positioning of theelectrodes on the body. Typically, electrodes are positioned to obtaingood signals from all regions of the heart. Organizations such asAmerican Heart Association (AHA) and International ElectrotechnicalCommission (IEC) provide guidelines for electrode positions for ECGmeasurements. While these recommended electrode positions result inacceptable ECG data, there remains a need for improved ECG measurementsystems and methods.

BRIEF DESCRIPTION OF THE FIGURES

The accompanying drawings, which are incorporated in and constitute apart of this specification, illustrate various exemplary embodiments andtogether with the description, serve to explain the principles of thedisclosed embodiments.

FIG. 1 illustrates an exemplary system for measuring ECG of a patient.

FIGS. 2A and 2B illustrate top and side views respectively of anexemplary adhesive patch used in the ECG measurement system of FIG. 1.

FIG. 3A illustrates a front view of a patient with an exemplary adhesivepatch attached.

FIG. 3B illustrates a top view of a patient with arms outstretched.

FIGS. 4A-4D illustrate other exemplary embodiments of an adhesive patchwhich may be used in the ECG measurement system of FIG. 1.

SUMMARY

In one aspect, a method of measuring bioelectric signals of a patienthaving an axis extending from the patient's head to the patient's feetis disclosed. The method may include attaching a patch to the patient'sskin. The patch may include a first electrode and a second electrodespaced apart along a longitudinal axis of the patch. The patch may beattached such that the longitudinal axis of the patch is generallyaligned with the axis of the patient. The method may also includeattaching a third electrode to the patient's skin, and measuringbioelectric signals of the patient using the first electrode, the secondelectrode, and the third electrode.

Additionally or alternatively, the method may include one or more of thefollowing aspects: the bioelectric signals may include ECG signals;attaching the patch may include attaching the patch under an arm pit ofthe patient; attaching the third electrode may include attaching thethird electrode above the right atrium of the patient's heart; themethod may further include electrically connecting the first electrode,the second electrode, and the third electrode to a portable monitor, andusing the monitor to measure the bioelectric signals; and attaching themonitor to the patch; attaching the patch to the patient's skin includesattaching the patch to a thoracic region spanning about 15° on eitherside of a linear axis extending through the patient's outstretched arms.

In another aspect, a method of measuring ECG signals of a patientincluding an axis extending from the patient's head to the patient'sfeet, is disclosed. The method may include attaching a patch under theleft armpit in the patient's thoracic region. The patch may include afirst electrode and a second electrode spaced apart along a longitudinalaxis of the patch, the patch being attached such that the longitudinalaxis is generally aligned with the axis of the patient. The method mayalso include attaching a third electrode to a chest of the patient, andmeasuring ECG signals using the first electrode, the second electrode,and the third electrode.

Additionally or alternatively, the method may include one or more of thefollowing aspects: electrically connecting the first electrode, thesecond electrode, and the third electrode to a portable monitor, andusing the monitor to measure the ECG signals; further include attachingthe monitor to the patch; the monitor is attached to the patch betweenthe first electrode and the second electrode; attaching the patchincludes attaching the patch to a thoracic region spanning about 15° oneither side of a linear axis extending through the patient'soutstretched arms; electrically connecting the third electrode to theportable monitor includes directing measured signals from the thirdelectrode to the patch; wherein the patch includes an adhesive layer ona surface covered by a protective strip, and the method further includesremoving the protective strip prior to attaching the patch.

In another aspect, an adhesive electrode patch for measuring bioelectricsignals from a patient is disclosed. The patch may include an elongatedflexible strip extending along a longitudinal axis from a first endregion to a second end region. The patch may also include a firstelectrode on the first end region, and a second electrode on the secondend region; and a central region located between the first end regionand the second end region. A width of the central region in a directiontransverse to the longitudinal axis is greater that a width of the firstand second end regions.

Additionally or alternatively, the patch may include one or more of thefollowing aspects: a skin-facing surface and an exposed surface oppositethe skin-facing surface, the skin-facing surface may include an adhesivelayer covered by a protective strip; the exposed surface of the stripmay include markings to assist a patient in aligning the strip on thepatient's body; the strip may include conductive traces extending fromthe first electrode and the second electrode to the central region; andthe strip may be made of a fabric material, and the first electrode andsecond the electrodes include silver.

DETAILED DESCRIPTION

Reference will be made in detail to exemplary embodiments of thedisclosure, examples of which are illustrated in the accompanyingdrawings. Wherever possible, the same reference numbers will be usedthroughout the drawings to refer to the same or like parts.

Embodiments of the present disclosure may include methods and systemsfor monitoring physiologic data of a patient. Various aspects of thepresent disclosure may be used in combination with, or include, one ormore features disclosed in U.S. Pat. No. 8,478,418 (issued Jul. 2, 2013)and U.S. Pat. No. 8,620,418 (issued Dec. 31, 2013), each of which areincorporated by reference herein in their entireties. While an exemplaryembodiment of measuring ECG data is described below, it should be notedthat, the current disclosure may be applied to the measurement of anyphysiologic data. For example, the disclosed systems and methods may beused to measure signals indicative of heart rate, activity level (e.g.,physical mobility or movement), respiration rate, blood pressure (e.g.,systolic and/or diastolic), blood oxygen saturation (SpO2), bloodglucose or insulin level, pulse oximetry, impedance, body temperature,etc. It is also contemplated that, in some embodiments, the measuredphysiologic data may be used to determine a cardiac safety indicatorsuch as QT prolongation, ST elevation, etc.

FIG. 1 is a schematic illustration of an exemplary system 100 formeasuring ECG of a patient 10. A plurality of electrodes 14, 16, 18 maybe attached to the patient 10 to detect ECG signals. The electrodes 14,16, 18 detect (and in some cases amplify) tiny electrical changes on theskin that are caused when heart muscles depolarize during eachheartbeat. At rest, each heart muscle cell has a negative charge (calledthe membrane potential) across its cell membrane. Decreasing thisnegative charge toward zero, via the influx of the positive cations (Na+and Ca++) is called depolarization. Depolarization activates mechanismsin the cell that cause it to contract. During each heartbeat, a healthyheart will have an orderly progression of a wave of depolarization thatis triggered by the cells in the sinoatrial node, spreads out throughthe atrium, passes through the atrioventricular node and then spreadsall over the ventricles. The depolarization wave (or ECG data) isindicative of the overall rhythm of the heart and is detected asvariations in voltage between the electrode pairs (e.g., betweenelectrodes 14-16, 14-18, and 16-18).

System 100 may include a monitor 20 operatively coupled to theelectrodes 14, 16, 18. Monitor 20 may be adapted to receive and storethe ECG data from the electrodes 14, 16, 18. Monitor 20 may be coupledto electrodes 14, 16, 18 wirelessly or using a wired connection. Inembodiments where the ECG data is transmitted to monitor 20 wirelessly,some or all of electrodes 14, 16, 18 may include a transceiver totransmit the measured ECG data to monitor 20. In some embodiments,monitor 20 may transfer at least a portion of the measured ECG data to aremote analysis station 60 for analysis. Although analysis station 60 isillustrated as a computer, in general, analysis 60 station may includeany collection of computational devices and personnel (e.g., one or moreservers, databases, and computers networked together).

The ECG data from monitor 20 may be transferred to remote analysisstation 60 over a wired connection, using a portable storage medium(transferable memory device, etc.), or transferred wirelessly over anelectronic network 50 (e.g., the internet). Rather than transferringdata directly to analysis station 60, in some embodiments, monitor 20may transfer the data to analysis station 60 through an intermediatedevice (e.g., cellular phone, PDA, etc.). That is, the ECG data frommonitor 20 may be first sent to an intermediate device such as acellular phone using Bluetooth or other similar technologies (HomeRF,IrDA, etc.), when monitor 20 is close to the cellular phone. The ECGdata from the cellular phone may then be sent to the analysis station 60over the phone's cellular communication network or the electronicnetwork 50.

Analysis station 60 may analyze the ECG data to check the cardiac healthof patient 10. Any analysis methodology known in the art may be used toanalyze the received data (e.g., a methodology described by Philip deChazal, et al., in “Automatic Classification of Heartbeats Using ECGMorphology and Heartbeat Interval Features,” IEEE Transactions onBiomedical Engineering, Vol. 51, No. 7, July, 2004). Since methods andalgorithms for analyzing ECG data are well known in the art, they arenot described herein. In some embodiments, monitor 20 may at leastpartially analyze the collected ECG data before it is transferred toanalysis station 60.

In some embodiments, monitor 20 may store the collected ECG data, andcontinuously transmit (directly or through an intermediate device) asubset of the data (e.g., data at a lower resolution, etc.) to theanalysis station 60. The analysis station 60 may analyze the receiveddata to determine if it indicates an anomaly (e.g., an arrhythmia, anunexpected trend in the data, etc.). If an anomaly is indicated,analysis station 60 may request (i.e. transmit instructions) the monitor20 for more data (e.g., data from the same time frame at a higherresolution, etc.). Upon receipt of this request, the monitor 20 mayretrieve the requested data from memory and transmit it to the analysisstation 60. The analysis station 60 may then analyze the data (e.g.,using a more rigorous analysis methodology) to confirm or refute theanomaly detected during the previous analysis. This analysis methodologyis described in more detail in U.S. Pat. No. 8,478,418, which isincorporated by reference herein.

Monitor 20 may be any type of portable monitor known in the art (e.g.,Holter monitor, event monitor, mobile cardiovascular telemetry (MCT)monitor, etc.). Monitor 20 may include integrated circuits(microprocessor, memory, communication devices, etc.), visual displays(LED, LCD, etc.), and/or buttons that can be activated by the patient10. The integrated circuits of monitor 20 may enable processing ofcollected ECG data, and communication between monitor 20, theintermediate device (if any), and the analysis station 60. The useractivatable buttons may enable the patient 10 to trigger an activity(data collection, communication with analysis station 60, etc.) when thepatient 10 feels uncomfortable (e.g., experiences chest pains, etc.),and the display may enable the monitor 20 and analysis station 60 tocommunicate with patient 10 (e.g., using text messages).

Monitor 20 may be a portable device, sized and adapted to be kept in thepossession (strapped, attached, placed in the pocket, etc.) of patient10. Such a portable monitor 20 may enable the patient 10 to go about thepatient's daily activities while the monitor 20 records (and/ortransfers) ECG data. In the exemplary embodiment illustrated in FIG. 1,monitor 20 is shown as a device attached (e.g., clipped) to thepatient's belt. However, this is only exemplary, and otherconfigurations are possible. For example, in some embodiments, monitor20 may be combined with, or incorporated into a cellular phone (oranother device, such as, watch, etc.). In embodiments where electrodes14, 16, 18 are connected by a wire to the monitor, monitor 20 mayinclude a connector to receive the connecting wire. In embodiments whereelectrodes 14, 16, 18 are coupled wirelessly, monitor 20 may include atransceiver to communicate with a transceiver of electrodes 14, 16, 18.

Electrodes 14, 16, 18 may be any type of electrodes that may be attachedto the skin of patient 10. In some embodiments, at least two of theelectrodes 16, 18 may be configured as an adhesive patch 30. FIGS. 2Aand 2B illustrate an exemplary embodiment of an adhesive patch 30. FIG.2A illustrates a top view of patch 30, and FIG. 2B illustrates its sideview. In the description that follows, reference will be made to bothFIGS. 2A and 2B. Adhesive patch 30 may be made of a flexible material(tape, fabric, etc.) that is adapted to conform to the contours of thepatient's skin. Adhesive patch 30 may be configured as a reusable patchor a disposable patch. In some embodiments, the material of adhesivepatch may have pores (or otherwise breathable) or other features toenhance patient comfort. One side (skin-facing side 34) of the adhesivepatch 30 may include an adhesive. Any type of adhesive (e.g., acrylates,silicones, hydrogels, hydrocolloids, polyurethanes, etc.) that canattach the adhesive patch 30 to the skin of the patient may be used. Insome embodiments, the adhesive may be coated to the skin-facing side 34of the adhesive patch 10. In some embodiments, the adhesive may becovered by a strip of removable protective material (e.g., similar toadhesive bandages such as Band-Aid). After removing this protectivestrip, the adhesive patch 30 may be attached on the patient by pressingthe skin-facing side 34 to the patient's skin. In this configuration,the side of patch 30 opposite to the skin-facing side (i.e., exposedside 36) is exposed to the atmosphere. Although patch 30 is described asbeing attached to the patient's skin using an adhesive layer, it is alsocontemplated that in some embodiments, patch 30 may be attached usingother attachment mechanisms (e.g., adhesive tape, sutures, clips, etc.).

In general, adhesive patch 30 may have any size and shape. In someembodiments, adhesive patch 30 may have an elongated shape (e.g., oval,elliptical, rectangular, dumbbell shaped, hour-glass shaped etc.) withan axis (longitudinal axis 32) extending along its length. Electrodes16, 18 may be spaced apart along the longitudinal axis 32 of adhesivepatch 30. In an exemplary embodiment, as illustrated in FIG. 2A, theelongated shape of patch 30 may include circular regions at its twoends, the sides of which converge to form narrower neck regions thatfurther expand to a wider central region 35. In the embodiment of FIG.2A, electrodes 16, 18 are placed on the circular regions and spacedapart by the wider central region 35. The wider central region 35 andthe circular end regions may have any dimensions suitable for itspurpose. In some embodiments (see FIG. 2A), the central region 35 may besized to attach a monitor 20 thereon.

Electrodes 16, 18 may include any material and configuration (size andshape) that are currently used for, or are suitable for, bioelectricmeasurements. See, Neuman, M. R., Chapter 40: Biopotential Electrodes,“Biopotential Electrodes,” The Biomedical Engineering Handbook: SecondEdition, Ed. Joseph D. Bronzino, Boca Raton, CRC Press LLC, 2000, whichis incorporated by reference herein. In some embodiments, electrodes 16,18 may have a substantially circular cross-sectional shape and be madeof silver with a surface layer of silver chloride. However, other shapes(square, rectangular, polygonal, etc.) are also contemplated. Electrodes16, 18 may be attached to the adhesive patch 30 in any manner (e.g.,adhesives, etc.). In some embodiments, the electrodes 16, 18 may bestitched or weaved into the material of the adhesive patch 30. In someembodiments, the material of electrodes 16, 18 may be deposited orcoated on the patch 30. In some embodiments, as illustrated in FIG. 2B,electrodes 16, 18 may have a region of reduced diameter along itsthickness (in a direction perpendicular to the plane of the paper), andmay be attached to patch 30 like a button.

In some embodiments, adhesive patch 30 may also include an electricallyconductive gel 38. The conductive gel 38 may be provided in a regionadjacent the electrodes 16, 18. Conductive gel 38 may be a viscousconductive medium that fills any gap between the electrodes 16, 18 andthe patient's skin to improve detectability of electrical activity underthe skin. Any type of commercial or specially formulated gel known inthe art may be used as conductive gel 38.

In some embodiments, conductive patch 30 may include conductive traces40, 44 that extend from the electrodes 16, 18 to terminals 42, 46 ofpatch 30. These traces 40, 44 may include any conductive material andmay be provided by any known additive and/or subtractive processes(masking and plating/deposition, plating/depositing and etching, etc.).These traces 40, 44 may extend along the skin-facing surface 34 or theexposed surface 36 of patch 30. The conductive traces 40, 44 may directthe measured bioelectric signals from electrodes 16, 18 to the terminals42, 46. The terminals 42, 46 may be the ends of traces 40, 44 positionedon the exposed surface 36 of the patch 30. In embodiments where thetraces 40, 44 extend along the skin-facing surface 34, a through-holevia may electrically connect ends of the traces 40, 44 to the terminals42, 46. In general, the terminals 42, 46 may be positioned anywhere onpatch 30. In some embodiments, the terminals 42, 46 may be positioned onan edge of patch 30. In such embodiments, an external wire attached to(e.g., clipped, etc.) the terminals 42, 46 may retrieve the measuredbioelectric signals from the patch 30. In some embodiments, asillustrated in FIG. 2A, the terminals 42, 46 may be positioned on thecentral region 35 of patch 30. In some such embodiments, patch 30 mayalso include a trace 54 that extends from a terminal 52 at an edge ofthe patch 30 to a terminal 56 at the central region 35. An external wireattached to terminal 52 may direct measured signals from electrode 14 toterminal 56. In some such embodiments, a monitor 20 attached to centralregion 35 may receive the measured signals from terminals 42, 46, and56.

In some embodiments, adhesive patch 30 may also include circuitry (notshown) to process (amplify, filter, etc.) the bioelectric signalsmeasured by the electrodes 16, 18 (and, in some embodiments, electrode14). In some embodiments, the circuitry may be formed directly on thematerial of patch 30 using fabrication techniques known in the art(e.g., using IC fabrication techniques). In some embodiments, thecircuitry may be formed on a discrete component (integrated circuitchip, printed circuit board, etc.) which is attached to the patch 30.The circuitry may be positioned anywhere on patch 30. In someembodiments, the circuitry may be positioned on the central region 35such that the measured signals are processed by the included circuitryon its way from an electrode to its corresponding terminal. Inembodiments where the bioelectric signals are wirelessly transmitted tomonitor 20, the circuitry may also include a transmitter (ortransceiver) circuit to transmit the signals to monitor 20.

FIG. 3A illustrates an adhesive patch 30 attached to patient 10. FIG. 3Adepicts the front view of a patient's thoracic region, and FIG. 3Billustrates a top view of the patient with arms outstretched. In thedescription that follows, reference will be made to both FIGS. 3A and3B. Patient 10 may have a vertical axis 12 extending from the patient'shead to the patient's feet and a horizontal axis 15, perpendicular tothe vertical axis 12, and extending along the patient's outstretchedarms. In general, patch 30 may be attached anywhere on the patient'sbody in any orientation. In some embodiments, adhesive patch 30 isattached to the thoracic region of the patient's torso with itslongitudinal axis 32 in a generally vertical orientation (i.e.head-feet). In this orientation, longitudinal axis 32 of patch 30 may begenerally aligned with the vertical axis 12 of patient 10. It should benoted that, because of different contours (curved, sloped, etc.) ondifferent regions of the patient's body, general alignment oflongitudinal axis 32 with vertical axis 12 (as used herein), does notnecessarily mean that the longitudinal axis 32 is parallel to thevertical axis 12. Instead, as illustrated in FIG. 3, the longitudinalaxis 32 may extend in the same direction as the vertical axis 12.

Adhesive patch 30 may be attached in a vertical orientation anywhere inthe thoracic region of patient 10. As is known to a person of ordinaryskill in the art, the thoracic region is the area above the diaphragmand includes the sternal region, the pectoral region, and the axillaryregion. The sternal region lies over the sternum or the breastbone, thepectoral region includes the region of the chest muscles on either sideof the sternum, and the axillary region is the area proximate thearmpits. In the exemplary embodiment illustrated in FIG. 3A, patch 30 isattached to a region under the left arm with its longitudinal axis 32generally aligned with the vertical axis 12. In this disclosure, aregion that spans the axillary region and the pectoral region near theaxillary region is considered to be under an arm. That is, a regionspanning an angle θ of about 15° on either side of the horizontal axis15 (see FIG. 3B) extending over the thoracic region is considered to beunder an arm.

Electrode 14 may be any type of electrode used in bioelectric signalmeasurement and may be attached anywhere in the patient's thoracicregion. In some embodiments, electrode 14 may be attached at anylocation where any one of V₁ to V₆ electrode is commonly positionedduring 12 lead ECG measurement. In some embodiments, electrode 14 may beattached to the sternal region or in the left pectoral region proximatethe sternal region. In some embodiments, electrode 14 may be positionedat a region above the right atrium of the patient's heart. Afterattaching the electrode 14 at the desired location, it is connected tothe monitor 20. In some embodiments, electrode 14 may be connected toterminal 52 of patch 30 using an external wire.

After the adhesive patch 30 is attached to the patient's skin, theelectrodes 16 and 18 are connected to the monitor 20. In embodimentswhere the monitor 20 is positioned remote from the patch 30, externalwires (e.g., from terminals 42, 46) may connect the electrodes 16, 18 tothe monitor 20 (see FIG. 1). In other embodiments, the signal from theelectrodes 16, 18 may be wirelessly transmitted to the monitor 20. Insome such embodiments, the measured signals from electrode 14 may bedirected to the patch 30 (through terminal 52) and signals from all theelectrodes 14, 16, 18 transmitted wirelessly to the monitor 20.

In some embodiments, as illustrated in FIG. 3A, the monitor 20 may beattached to the patch 30. The monitor 20 may be attached to the patch 30at any location and by any method (adhesive, mechanical fastener, strap,etc.). In some embodiments, the monitor 20 may be detachably clipped(e.g., using a clip) to the central region 35 of patch 30. In someembodiments, a hook and loop system (e.g., Velcro fasteners) may attachmonitor 20 to the patch 30. In some embodiments, a strap may couple themonitor 20 to the patch 30. It is also contemplated that, in someembodiments, the patch 30 may have a recess that securely receives themonitor 20 therein. The terminals 42, 46, and 56 may also be connectedto the monitor 20 to receive the measured signals from the electrodes14, 16, 18. In some embodiments, when the monitor 20 is attached to thepatch 30, the terminals 42, 46, and 56 of the patch 30 may mate withcorresponding terminals of the monitor 20 to direct the signals into themonitor 20.

As described above, these electrode measured signals may be stored,processed, and/or transmitted from the patch 30 to a remote analysisstation 60 directly or through an intermediate device. The analysisstation 60 may analyze the measured data to identify an anomaly.

It should be noted that the shape and configuration of the adhesivepatch 30 illustrated in FIG. 2A is only exemplary. In general, patch 30may have any shape suitable for its purpose. FIGS. 4A-4D illustrate someexemplary shapes of patch 30 with two electrodes 16, 18 spaced apartalong a longitudinal axis 32. As illustrated in FIG. 4A, in someembodiments, the end portions of the patch 30 may have a generallysquare or a rectangular configuration and the central region 35 may havea generally circular configuration. The central region 35 may includesome circuit elements 37 (filter, A/D converter, etc.) formed thereon toat least partially process the measured bioelectric signals from theelectrodes 16, 18. These processed signals may be received by a monitor20 attached to central region 35 or positioned elsewhere on the patient10.

FIG. 4B illustrates an exemplary patch 30 having a generally rectangularshape, and FIG. 4C illustrates an exemplary patch 30 having a generallyelliptical shape. As illustrated in FIGS. 4B and 4C, in someembodiments, patch 30 may have markings 33 thereon, for example, arrowsor a line. These markings 33 may assist in generally aligning thelongitudinal axis 32 of the patch 30 with the vertical axis 12 of thepatient 10. FIG. 4D illustrates an exemplary patch 30 in which the endportions and the central region 35 is configured to be substantiallycircular. As illustrated in FIG. 4D, in some embodiments, patch 30 mayinclude an indicator 39 that alerts the patient 10 when it is time toreplace the patch 30. For example, indicator 39 may change color withtime, and the patient may be advised to change the patch 30 when theindicator 39 becomes a particular color (red, etc.).

Adhesive patches 30 may also include other features not described withreference to the figures. For instance, patch 30 may include markings(e.g., to identify the name of the manufacturer) and text to assist(e.g., directions of use) the patient in use of the patch 30. It is alsocontemplated that other sensors (e.g., temperature sensor,accelerometer, sensor to analyze sweat, etc.) may be incorporated intopatch 30. For example, in some embodiments, indicator 39 of FIG. 4D maybe a sensor that changes color with temperature, in the presence of aconstituent in sweat, etc. It should be noted that while certainfeatures (e.g., markings 33, indicator 39) have been described inconnection with various embodiments, it is to be understood that anyfeature described in conjunction with any embodiment disclosed hereinmay be used with any other embodiment disclosed herein.

While the current disclosure describes using an adhesive patch for ECGmonitoring, it should be understood that the disclosure is not limitedthereto. Rather, the principles of the systems and methods describedherein may be employed for the measurement of any physiologic data of apatient. Those having ordinary skill in the art and access to theteachings provided herein will recognize additional modifications,applications, embodiments, and substitution of equivalents all fallwithin the scope of the embodiments described herein.

1-20. (canceled)
 21. A system for measuring bioelectric signals from auser, comprising: a patch configured to be attached under the user's armsuch that a longitudinal axis of the patch is generally aligned with anaxis that extends from the user's head to the user's feet, the patchincluding a first electrode and a second electrode spaced apart alongthe longitudinal axis; a third electrode spaced apart from the patch andconfigured to be attached to the user's chest; and a monitor operativelycoupled to the first electrode, the second electrode, and the thirdelectrode, the monitor being configured to measure bioelectric signalsof the user using the first electrode, the second electrode, and thethird electrode.
 22. The system of claim 21, wherein the bioelectricsignals include ECG signals.
 23. The system of claim 21, wherein thethird electrode is configured to be attached to (a) a sternal region or(b) a left pectoral region proximate the sternal region of the user. 24.The system of claim 21, wherein the third electrode is configured to beattached above a right atrium of the user's heart.
 25. The system ofclaim 21, wherein the monitor is configured to be physically attached tothe patch.
 26. The system of claim 21, wherein the patch is configuredto be attached to the user's thoracic region at in area spanning about15° on either side of a linear axis that extends through the user'soutstretched arms.
 27. The system of claim 21, wherein the monitor isconfigured to (a) store the measured bioelectric signals, and/or (b)transmit at least a portion of the measured bioelectric signals to aremotely located analysis device.
 28. The system of claim 21, whereinthe system further includes an analysis device positioned remote fromthe monitor and the patch, and wherein (a) the monitor is configured totransmit a first portion of the measured bioelectric signals to theanalysis device, (c) the analysis device is configured analyze the firstportion of the bioelectric signals received from the monitor todetermine if an anomaly is indicated, (d) the analysis device isconfigured to send a request to the monitor for additional data ifanalysis of the first portion indicates the anomaly, and (e) the monitoris configured to transmit a second portion of the measured bioelectricsignals to the analysis device in response to the request from theanalysis device for additional data, and (f) the analysis device isconfigured analyze the second portion of the bioelectric signalsreceived from the monitor to confirm the indicated anomaly.
 29. Thesystem of claim 21, wherein the patch is an adhesive patch that includesa flexible material adapted to conform to contours of the user's bodyand signal processing circuitry formed in the flexible material.
 30. Thesystem of claim 21, wherein a shape of the adhesive patch is one ofoval, elliptical, rectangular, dumbbell shaped, and hour-glass shaped.31. The system of claim 21, wherein the patch is configured to beattached under the user's left arm.
 32. The system of claim 21, whereinthe patch is a disposable patch, and wherein the patch includes anindicator configured to alert the user when it is time to replace thepatch.
 33. A method of measuring bioelectric signals of a user,comprising: attaching a patch under the user's arm such that alongitudinal axis of the patch is generally aligned with an axis thatextends from the user's head to the user's feet, the patch including afirst electrode and a second electrode spaced apart along thelongitudinal axis; attaching a third electrode to the user's chest,wherein the third electrode is separate from the patch; operativelycoupling a monitor to the first electrode, second electrode, and thethird electrode; and measuring bioelectric signals using the monitor.34. The method of claim 33, further including attaching the monitor tothe patch.
 35. The method of claim 34, wherein attaching the monitor tothe adhesive patch includes attaching the monitor between the firstelectrode and the second electrode.
 36. The method of claim 33, whereinattaching the patch under the user's arm includes attaching the patch tothe user's thoracic region in an area spanning about 15° on either sideof a linear axis that extends through the user's outstretched arms. 37.The method of claim 33, wherein attaching the third electrode includesattaching the third electrode above a right atrium of the user's heart.38. The method of claim 33, further including transmitting at least aportion of the measured bioelectric signals from the monitor to a remotedevice.
 39. The method of claim 33, wherein the measuring bioelectricsignals includes measuring ECG signals.
 40. The method of claim 33,further including storing at least a portion of the measured bioelectricsignals in the monitor.